Indirect Costs Associated With Nonadherence to Treatment for Bipolar Disorder
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association between treatment adherence and indirect productivity costs within a cohort of commercially insured employees with bipolar disorder in the United States. METHODS: Adults diagnosed with bipolar disorder who had at least one prescription claim for a mood stabilizer or atypical antipsychotic, with 6 months prior and 12 months subsequent continuous medical and prescription coverage, were identified in the MarketScan research databases (2000-2005). Two-part multiple regression models estimated the association between adherence (medication possession ratio > or =0.80) and costs of absence, short-term disability, and workers' compensation. RESULTS: Of 1258 eligible employees, only 35.3% were adherent. Relative to adherent employees, nonadherent employees had higher adjusted indirect costs due to absence (+$771.41), short-term disability (+$284.72), and workers' compensation (+$360.63). CONCLUSIONS: Employers incur greater indirect costs when employees are not adherent to bipolar treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bagalman et al25 focused primarily on the indirect costs associated with non-adherence—short-term disability, workers’ compensation and paid time off costs”
From Economic impact of medication non-adherence by disease groups: a systematic review (2018) · cites this paper as [25]
Citations
Cites
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1561 · Cited by 868
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1561 · Cited by 868
Goetzel, R. Z., Hawkins, K., Ozminkowski, R. J., & Wang, S. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200301000-00007 · Cited by 694
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603
Nonadherence With Mood Stabilizers: Prevalence and Predictors
Scott, J., & Pope, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0502 · Cited by 315
An economic evaluation of manic-depressive illness-1991
Wyatt, R. J., & Henter, I. (1995) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00789056 · Cited by 312
The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
Begley, C. E., Annegers, J. F., Swann, A. C., Lewis, C., Coan, S., Schnapp, W. B., & Bryant-Comstock, L. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119050-00004 · Cited by 265
Treatment adherence with antipsychotic medications in bipolar disorder
Sajatovic, M., Valenstein, M., Blow, F. C., Ganoczy, D., & Ignacio, R. V. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00314.x · Cited by 242
Treatment Adherence With Lithium and Anticonvulsant Medications Among Patients With Bipolar Disorder
Sajatovic, M., Valenstein, M., Blow, F., Ganoczy, D., & Ignacio, R. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.855 · Cited by 172
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s259338 · Cited by 147
Mood disorders medications: predictors of nonadherence – review of the current literature
Pompili, M., Venturini, P., Palermo, M., Stefani, H., Seretti, M. E., Lamis, D. A., Serafini, G., Amore, M., & Girardi, P. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811976 · Cited by 120
“…questionnaire: the BMQ BD Younger age, more medications, patients’ belief about treatment and illness in regard to its consequences and timeline [11] Bagalman et al. (2010) I = 1 II = 2 III = 22 IV = 2 V = 1 VI = 2 Total score = 10 Cohort study Prescription records: MPR BD Have a recent diagnosis…”
BackgroundCuevas, C. D. L., de León, J., Peñate, W., & Betancort, M. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s133513 · Cited by 70
“17,18 21 Previous research has shown that treatment adherence is a multidimensional phenomenon determined by the interplay of different factors including patient-related, environment-related, medication-related, disorder-related, and other treatment-related factors.”
Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning
Maurino, J., Montes, De dios, C., & Medina (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s39290 · Cited by 66
“In addition, bipolar patients use health care services more than patients with other mental disorders.(2,3) The presence of mood episodes in bipolar disorder has a strong association with poor functioning.”
Vieta, E., Azorin, J., Bauer, M., Frangou, S., Perugi, G., Martínez, G., & Schreiner, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.041 · Cited by 52
Lumbar discectomy is associated with higher rates of lumbar fusion
Castillo, H., Chintapalli, R. T. V., Boyajian, H. H., Cruz, S. A., Morgan, V. K., Shi, L. L., & Lee, M. J. (2018) · The Spine Journal · doi:10.1016/j.spinee.2018.05.016 · Cited by 33
WENZE, S. J., ARMEY, M. F., WEINSTOCK, L. M., GAUDIANO, B. A., & MILLER, I. W. (2016) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000196 · Cited by 27
Owusu‐Edusei, K., Roby, T., Chesson, H. W., & Gift, T. L. (2013) · Sexual Health · doi:10.1071/sh13021 · Cited by 29
Lu, K., Xiong, X., Brown, J., Horras, A., Yuan, J., & Li, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.706289 · Cited by 24
“Similarly, it has been found that nonadherent patients with bipolar disorder have increased indirect costs compared to adherent cohorts (Bagalman et al., 2010).”
BackgroundSchulz, R., Porter, C. N., Lane, M. J., Cornman, C. B., & Branham, L. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.02.008 · Cited by 22
Okasha, T. A., Radwan, D. N., Elkholy, H. A., Hendawy, H., Shourab, E. M. M. E., Teama, R., & Abdelgawad, A. S. (2020) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v26i0.1437 · Cited by 22
Bäck, A., Sundell, K. A., Horne, R., Landén, M., & MÅRDBY, A.-C. M. (2012) · The International Journal of Person Centered Medicine · doi:10.5750/ijpcm.v2i2.160 · Cited by 15
Patterns of atypical antipsychotic therapy use in adults with bipolar I disorder in the USA
Chen, W., DeVeaugh‐Geiss, A., Palmer, L. A., Princic, N., & Chen, Y. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2326 · Cited by 12
Doane, M. J., Ogden, K., Bessonova, L., O’Sullivan, A. K., & Tohen, M. F. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s280051 · Cited by 14
“3%) were adherent with their regimen over a year of follow-up.(29) There were three analyses that reported relatively high adherence rates for patients prescribed antipsychotics (MPRs ranged from 0.”
BackgroundForma, F. M., Chiu, K., Shafrin, J. T., Boskovic, D. H., & Veeranki, S. P. (2022) · Digital Health · doi:10.1177/20552076221084472 · Cited by 14
“S is $195 billion, $325 billion and $155 billion, respectively9–11 with 70–80% of burden attributed to indirect costs that include productivity loss or unemployment by patients or caregivers, missed time at school, medication adherence issues and caregiving support.(9,12,13) Patients with SMI face several mental, beha…”
BackgroundXIA, X. S., Poremski, D., UBANA, R. L., & Ravichandran, N. (2020) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000482 · Cited by 12
“2) Male 156 (100) Involuntary admission 84 (54) Length of admission [median (IQR)] (d) 19 (10-38) Class of medication Antipsychotic 76 (49) Antidepressant 19 (12) Mood stabilizer 4 (3) Antipsychotic and antidepressant 29 (18) Antipsychotic and mood stabilizer 24 (15) Antipsychotic, antidepressant, and mood stabilizer…”
BackgroundWu, R., Kemp, D. E., Sajatovic, M., Zhao, J., Calabrese, J. R., & Gao, K. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.013 · Cited by 6
Prajapati, A. R., Scott, S., Dima, A. L., Clark, A., Taylor, J., Wilson, J., & Bhattacharya, D. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.149 · Cited by 5
Disability and Overall Burden Related with Bipolar Disorder
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_12 · Cited by 4
Vukicevic, D., Tatovic, S., Zah, V., Hurley, D. C., & Imro, M. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1770085 · Cited by 3
Factors influencing adherence to psychopharmacological medication – the doctors' perspective
Peska, M., Artmüller, S., Rothenberg, M., Winkler, D., & Pjrek, E. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.09.069 · Cited by 2
Rajagopalan, K., Wade, S., Chu, B. C., & Loebel, A. D. (2016) · Medical economics · Cited by 4
Tohen, M. F., Yildirim, M., Loomer, S., Micheelsen, A., Harrsen, K., Beckham, C., Nag, S. S., Bates, D., Guillaume, X., & Such, P. (2026) · International Journal of Bipolar Disorders · doi:10.1186/s40345-026-00414-0 · Cited by 1
Chatterton, M. L., Lee, Y. Y., Berk, L., Mohebbi, M., Berk, M., Suppes, T. M., Lauder, S., & Mihalopoulos, C. (2022) · JMIR Mental Health · doi:10.2196/36496 · Cited by 1
Kamaru-kwobah, E. W. (2013) · Cited by 1
Poole, R. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Systems-Based Patient Work Analyses of Older Adults with Heart Failure
Mickelson, R. S. (2017)
Nag, S. S., Urganus, A., Lynum, K. S. B., Atkins, N., Baser, O., Rodchenko, K., Awasthi, S., & Harrsen, K. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1904737
Metadata
- Authors
- Bagalman, E., Yu-Isenberg, K. S., Durden, E., Crivera, C., Dirani, R., & Bunn, W. B.
- Affiliations
- Thomson Reuters (United States) (US)
- Northwestern University (US)
- Corresponding author
- Bagalman, Erin
- ORCID
- Durden, Emily
- Venue
- Journal of Occupational & Environmental Medicine
- Published
- 2010-05
- Volume
- 52
- Issue
- 5
- Pages
- 478-485
- ISSN
- 1076-2752 (ISSN-L)
- OpenAlex
- W1972371326
- Cited by
- 32
- References
- 22
- Citations by year
- 2026: 2 · 2025: 2 · 2022: 2 · 2021: 2 · 2020: 5 · 2018: 2 · 2017: 2 · 2016: 3 · 2014: 2 · 2013: 5 · 2012: 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Occupational and Environmental Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- bipolar disorder, medication adherence, indirect costs, productivity costs, absenteeism, short-term disability, workers' compensation, mood stabilizers, atypical antipsychotics, employer costs
- MeSH terms
- Adolescent, Adult, Bipolar Disorder, Costs and Cost Analysis, Female, Humans, Male, Middle Aged, Patient Compliance, United States, Workers' Compensation, Databases, Factual, Sick Leave, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.